Syngene International Ltd share price logo

Syngene International Ltd Share Price

(SYNGENE)

₹714.6▲1.46%

as on 04:01PM, 20 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Option Chain

🔔 Rating Alert

Macquarie has initiated outperform ratings for Syngene, expecting a price target implying an upside of 19-30% over the next 12 months.

Syngene International Ltd Performance

  • Day's Low

    Day's High

    ₹693.55
    Day's Price Range
    ₹717.7

  • 52 Week's Low

    52 Week's High

    ₹607.65
    52-Week Price Range
    ₹960.6
1 Month Return-14.28 %
3 Month Return-16.83 %
1 Year Return-6.72 %
Previous Close₹704.35
Open₹703.00
Volume14.41L
Upper Circuit-
Lower Circuit-
Market Cap₹28,352.69Cr

Syngene International Ltd Key Statistics

P/E Ratio

56.35

PEG Ratio

433.45

Market Cap

₹28,352.69 Cr

P/B Ratio

6.73

EPS

12.69

Dividend Yield

0.18

Sector

Healthcare

ROE

11.95

Syngene International Ltd Analyst Rating

based on 8 analysts

HOLD

50.00%

Buy

12.50%

Hold

37.50%

Sell

Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹878.12

Source: S&P Global Market Intelligence

Syngene International Ltd Share analysis

Syngene International Ltd price forecast by 8 analysts

Upside of24.67%

High

₹1030

Target

₹878.12

Low

₹700

Syngene International Ltd target price ₹878.12, a slight upside of 24.67% compared to current price of ₹714.6. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Key events for Syngene International Ltd

  • Syngene Receives Positive Ratings and Growth Outlook - 20 Feb, 2025

    Macquarie initiates coverage on Syngene with an Outperform rating, predicting significant upside potential. The company is well-positioned for growth through capacity expansion and strong customer relationships.

  • Syngene International Receives Positive Ratings and Target Price - 19 Feb, 2025

    Syngene International is highlighted by Macquarie with an Outperform rating and a target price of Rs 835, indicating significant upside potential. Meanwhile, Kotak Mutual Fund has exited its position in the company.

  • Syngene International Sees Increased Trading Volume - 18 Feb, 2025

    On February 18, 2025, Syngene International Ltd experienced a significant increase in trading volume, reaching 25,665 shares, a 2.31-fold rise over the two-week average. The stock price rose by 0.61% to Rs. 705.65.

  • Syngene International Appoints New CEO - 10 Feb, 2025

    Syngene International announced the resignation of Jonathan Hunt as MD&CEO, appointing Peter Bains as CEO Designate effective February 10, 2025. Bains, a former CEO, brings extensive experience in the biotech and pharmaceutical industry.

  • Syngene Reports Strong Revenue Growth in Q3 - 31 Jan, 2025

    Syngene International's research services division registered an 11% increase in revenue to Rs 944 crore in the third quarter, indicating strong performance year-over-year.

  • Syngene Reports Strong Q4 Results for December 2024 - 28 Jan, 2025

    Syngene International reported a 10.57% increase in net sales to Rs 943.70 crore for December 2024, with net profit rising 17.58% to Rs 131.10 crore. EBITDA also grew by 15.76%. EPS increased to Rs 3.27. However, shares have seen a -3.87% return over the last six months.

  • Syngene Lowers FY25 Guidance Amid Market Challenges - 24 Jan, 2025

    Syngene International's stock fell sharply after the company revised its FY25 revenue guidance to single-digit growth and flat profit, citing delayed demand recovery. Despite a strong Q3 performance, the market reacted negatively to the outlook, leading to a significant drop in share price.

  • Syngene Reports Q3 Growth Amid Missed Estimates - 23 Jan, 2025

    Syngene International's Q3 results show an 18% profit increase to Rs 131 crore, with revenue up 10.6%. However, the company missed profit estimates and adjusted its full-year guidance to single-digit growth.

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 839.8 Cr → 962.0 Cr (in ₹), with an average increase of 6.6% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 6.74% to 6.80% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SYNGENE stock has moved up by 0.3%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.58% to 15.40% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 75.7 Cr → 131.1 Cr (in ₹), with an average increase of 23.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 165.3% return, outperforming this stock by 136.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 95.6% return, outperforming this stock by 102.4%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 54.72% to 52.74% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 20.72% to 20.64% in Dec 2024 quarter

Syngene International Ltd Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹853.50Cr (-)₹916.90Cr (↑7.43%)₹789.70Cr (↓13.87%)₹891.00Cr (↑12.83%)₹943.70Cr (↑5.91%)
Net Income₹111.50Cr (-)₹188.60Cr (↑69.15%)₹75.70Cr (↓59.86%)₹106.10Cr (↑40.16%)₹131.10Cr (↑23.56%)
Net Profit Margin13.06% (-)20.57% (↑57.50%)9.59% (↓53.38%)11.91% (↑24.19%)13.89% (↑16.62%)
Value in ₹ crore
Details2021202220232024
Total Assets₹4,977.30Cr (-)₹5,686.00Cr (↑14.24%)₹5,970.10Cr (↑5.00%)₹5,962.40Cr (↓0.13%)
Total Liabilities₹2,159.00Cr (-)₹2,394.00Cr (↑10.88%)₹2,351.20Cr (↓1.79%)₹1,770.90Cr (↓24.68%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹677.40Cr (-)₹698.00Cr (↑3.04%)₹582.20Cr (↓16.59%)₹838.40Cr (↑44.01%)₹913.40Cr (↑8.95%)

Index Inclusions

Nifty Healthcare

₹13,375.50

0.09 (▲11.65%)

BSE Healthcare

₹40,263.69

0.4 (▲159.55%)

Nifty LargeMidcap 250

₹14,528.15

0.73 (▲104.75%)

S&P BSE SmallCap Select

₹6,871.80

1.2 (▲81.35%)

S&P BSE 150 MidCap

₹14,175.42

1.24 (▲173.19%)

S&P BSE 400 MidSmallCap

₹10,582.55

1.23 (▲128.5%)

BSE 500

₹32,757.57

0.46 (▲149.8%)

Nifty MidSmallcap 400

₹17,400.70

1.28 (▲219.75%)

S&P BSE 250 LargeMidCap

₹9,778.61

0.38 (▲37.32%)

Nifty Midcap 150

₹18,888.80

1.31 (▲243.9%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

Nifty 500

₹20,831.10

0.48 (▲99.65%)

BSE Small-Cap

₹46,054.94

1.32 (▲599.11%)

Syngene International Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
52.74%
-3.63
Foreign Institutions
20.64%
-0.37
Mutual Funds
15.4%
13.46
Retail Investors
6.8%
0.91
Others
4.42%
4.12

Syngene International Ltd Key Indicators

Details20202021202220232024
Return On Equity %17.2816.1712.8913.6911.95
Details20202021202220232024
Return On Assets %9.78.136.967.788.55
Details20202021202220232024
Book Value Per Share (₹)54.470.5482.2890.13105.92
Details20202021202220232024
Earning Per Share (₹)10.310.129.8811.5712.69

Syngene International Ltd Valuation

Syngene International Ltd in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Today (56.35x)

February 19, 2025

Industry (92.99x)

February 19, 2025

Highest (78.92x)

December 2, 2024

LowHigh

Syngene International Ltd Earnings and Dividends

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit jumped 17.58% since last year same period to ₹131.10Cr in the Q3 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated 23.56% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Syngene International Ltd Dividends April,2024

    In the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.35%.

    Read More about Dividends

Syngene International Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Syngene International Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Syngene International Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Syngene International Ltd
Syngene International Ltd
HOLD₹28,352.69 Cr25.89%0.56₹510 Cr₹3,488 Cr
Sanofi India Ltd
Sanofi India Ltd
BUY₹12,048.61 Cr-5.69%0.52₹602 Cr₹2,851 Cr
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
BUY₹66,515.75 Cr17.86%0.56₹3,168 Cr₹29,001 Cr
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd
HOLD₹89,700.73 Cr43.85%0.64₹3,854 Cr₹19,547 Cr
Abbott India Ltd
Abbott India Ltd
BUY₹63,157.44 Cr18.28%0.53NANA
See all

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Share Price: ₹714.60 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹28,352.69Cr as of today
Revenue: ₹943.70Cr as on December 2024 (Q4 24)
Net Profit: ₹131.10Cr as on December 2024 (Q4 24)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

FAQs on Syngene International Ltd

What is Syngene International Ltd price today?

Syngene International Ltd share price today stands at ₹714.6, Open: ₹703, Previous Close: ₹704.35, High: ₹717.7, Low: ₹693.55, 52 Week High: ₹960.6, 52 Week Low: ₹607.65.

How to Buy Syngene International Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Syngene International Ltd shares

Is Syngene International Ltd listed on NSE?

Syngene International Ltd is listed on NSE

Is Syngene International Ltd listed on BSE?

Syngene International Ltd is listed on BSE

What are today's High and Low prices of Syngene International Ltd?

  • Today's highest price of Syngene International Ltd is ₹717.7.
  • Today's lowest price of Syngene International Ltd is ₹693.55.

What are today's traded volumes of Syngene International Ltd?

Today's traded volume of Syngene International Ltd(SYNGENE) is 14.41L.

What is today's market capitalisation of Syngene International Ltd?

Today's market capitalisation of Syngene International Ltd(SYNGENE) is ₹28352.69Cr.

What is the 52 Week High and Low Range of Syngene International Ltd?

Syngene International Ltd (SYNGENE)
Price
52 Week High
₹960.6
52 Week Low
₹607.65

How much percentage Syngene International Ltd is down from its 52 Week High?

Syngene International Ltd (SYNGENE) share price is ₹714.6. It is down -25.61% from its 52 Week High price of ₹960.6

How much percentage Syngene International Ltd is up from its 52 Week low?

Syngene International Ltd (SYNGENE) share price is ₹714.6. It is up 17.60% from its 52 Week Low price of ₹607.65

What are the historical returns of Syngene International Ltd?

Syngene International Ltd (SYNGENE)
Returns
1 Day Returns
10.25%
1 Month Returns
-14.28%
3 Month Returns
-16.83%
1 Year Returns
-6.72%

What is the PE ratio of Syngene International Ltd today?

PE Ratio of Syngene International Ltd is 56.35

PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share